{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:50:28Z","timestamp":1755035428991,"version":"3.41.2"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Strategies to ensure high intraocular oxygen delivery to the developing retina after 32 weeks gestational age, such as higher saturation targets and\/or higher hemoglobin levels, are hypothesized to prevent ophthalmological treatment for retinopathy of prematurity (ROP). This short report summarizes the current evidence of these strategies, and discusses possibilities of future studies. A large sample size would be required and therefore the feasibility of a future randomized controlled trial is questioned.<\/jats:p>","DOI":"10.3389\/fped.2022.975613","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T07:01:05Z","timestamp":1666594865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Considerations for future studies on the effect of late phase oxygen strategies on retinopathy of prematurity"],"prefix":"10.3389","volume":"10","author":[{"given":"Charlotte M.","family":"Nusman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline E.","family":"Schalij-Delfos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf\u00a0H. H.","family":"Groenwold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wes","family":"Onland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstrom","year":"2013","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/aos.14501","article-title":"Increase in treatment of retinopathy of prematurity in The Netherlands from 2010 to 2017","volume":"99","author":"Trzcionkowska","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1542\/neo.21-4-e249","article-title":"Strategies to prevent severe retinopathy of prematurity: a 2020 update and meta-analysis","volume":"21","author":"Raghuveer","year":"2020","journal-title":"Neoreviews"},{"key":"B5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1067\/mpa.2000.105823","article-title":"On \u201csupplemental therapeutic oxygen for prethreshold retinopathy of prematurity (stop-rop), a randomized, controlled trial. I: primary outcomes\u201d","volume":"4","author":"Flynn","year":"2000","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1167\/iovs.16-20822","article-title":"Use of a supplemental oxygen protocol to suppress progression of retinopathy of prematurity","volume":"58","author":"Colaizy","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1001\/jama.2020.10690","article-title":"Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ettno randomized clinical trial","volume":"324","author":"Franz","year":"2020","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1056\/NEJMoa2020248","article-title":"Higher or lower hemoglobin transfusion thresholds for preterm infants","volume":"383","author":"Kirpalani","year":"2020","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1542\/peds.104.3.514","article-title":"The effect of blood transfusion protocol on retinopathy of prematurity: a prospective, randomized study","volume":"104","author":"Brooks","year":"1999","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2288-3-26","article-title":"Analysis and presentation of factorial randomised controlled trials","volume":"3","author":"Montgomery","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jclinepi.2003.08.009","article-title":"Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test","volume":"57","author":"Brookes","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12874-019-0754-4","article-title":"Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes","volume":"19","author":"Vickerstaff","year":"2019","journal-title":"BMC Med Res Methodol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.975613\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T07:01:08Z","timestamp":1666594868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.975613\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":12,"alternative-id":["10.3389\/fped.2022.975613"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.975613","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"article-number":"975613"}}